Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

President and CEO

General Counsel

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is also developing ATYR2810, a fully humanized monoclonal antibody that is in preclinical development for the treatment of solid tumors. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. The company was incorporated in 2005 and is headquartered in San Diego, California.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-06	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-02-05	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-05	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-05	Premium	acquired	Premium	Premium	Premium	General Counsel
2023-12-12	Premium	bought	Premium	Premium	Premium	President and CEO
2023-12-11	Premium	bought	Premium	Premium	Premium	President and CEO
2023-11-13	Premium	bought	Premium	Premium	Premium	President and CEO
2023-11-10	Premium	bought	Premium	Premium	Premium	President and CEO
2023-07-28	Premium	bought	Premium	Premium	Premium	President and CEO
2023-05-17	Premium	gifted	Premium	Premium	Premium	-
2023-05-17	Premium	gifted	Premium	Premium	Premium	-
2023-05-10	Premium	bought	Premium	Premium	Premium	-
2023-04-26	Premium	acquired	Premium	Premium	Premium	-
2023-04-26	Premium	acquired	Premium	Premium	Premium	-
2023-04-26	Premium	acquired	Premium	Premium	Premium	-
2023-04-26	Premium	acquired	Premium	Premium	Premium	-
2023-04-26	Premium	acquired	Premium	Premium	Premium	-
2023-04-26	Premium	acquired	Premium	Premium	Premium	-
2023-02-06	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-02-03	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-02-03	Premium	acquired	Premium	Premium	Premium	General Counsel
2023-02-03	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-11-21	Premium	bought	Premium	Premium	Premium	President and CEO
2022-07-01	Premium	bought	Premium	Premium	Premium	President and CEO
2022-01-13	Premium	bought	Premium	Premium	Premium	Chief Financial Officer

LIFE - aTyr Pharma Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for LIFE